S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction|
|Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product|
|Mylan Wins Motion for Temporary Restraining Order Against Apotex for Authorized Generic of Paxil® CR|
|Mylan to Acquire U.S. Rights to Arixtra® (fondaparinux sodium) Injection from Aspen|
|Mylan Launches Generic Precedex™ Injection - Another Key Product Approval|
|Mylan Increases Third Quarter and Full Year 2014 Adjusted Diluted EPS Guidance Range|
|Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex™|
|Mylan raises outlook after better-than-expected third quarter|
|Analyst sees growth potential for Mylan; shares jump|
|Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan|
Click above to view more mutual fund data and stats for myl - Mylan Inc.